Ardelyx, Inc. (ARDX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Ardelyx, Inc. (ARDX)
Go deeper and ask any question about ARDX
Company Performance
Current Price
as of Sep 13, 2024$6.31
P/E Ratio
N/A
Market Cap
$1.49B
Description
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
Metrics
Overview
- HQWaltham, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerARDX
- Price$6.31+1.45%
Trading Information
- Market Cap$1.49B
- Float96.28%
- Average Daily Volume (1m)2,604,872
- Average Daily Volume (3m)4,237,611
- EPS-$0.28
Company
- Revenue$210.00M
- Rev Growth (1yr)227.86%
- Net Income-$16.45M
- Gross Margin86.34%
- EBITDA Margin-17.84%
- EBITDA-$13.06M
- EV$1.66B
- EV/Revenue7.89
- P/EN/A
- P/S7.05